LA JOLLA PHARMACEUTICAL CO - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 2, 2020

Attached files

file	filename
EX-32.1 - EXHIBIT 32.1 - LA JOLLA PHARMACEUTICAL CO	exhibit321fy201910-k.htm
EX-31.1 - EXHIBIT 31.1 - LA JOLLA PHARMACEUTICAL CO	exhibit311fy201910-k.htm
EX-23.1 - EXHIBIT 23.1 - LA JOLLA PHARMACEUTICAL CO	exhibit231fy2019.htm
EX-10.5 - EXHIBIT 10.5 - LA JOLLA PHARMACEUTICAL CO	exhibit105fy201910-k.htm
EX-10.1 - EXHIBIT 10.1 - LA JOLLA PHARMACEUTICAL CO	exhibit101fy201910-k.htm
EX-4.2 - EXHIBIT 4.2 - LA JOLLA PHARMACEUTICAL CO	exhibit42fy201910-k.htm
10-K - 10-K - LA JOLLA PHARMACEUTICAL CO	ljpc-201910xk.htm

Exhibit 21.1

Subsidiaries of La Jolla Pharmaceutical Company



Name of Subsidiary		Jurisdiction
La Jolla Pharma, LLC		Delaware
La Jolla Pharmaceutical I B.V.		Netherlands
La Jolla Pharmaceutical II B.V.		Netherlands
La Jolla Pharmaceutical III B.V.		Netherlands
La Jolla Pharmaceutical Australia Pty Ltd		Australia